Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terry C Burns

Showing results (91-100 of 111) with videos related to

Pageof 12
Sort By:
Nature Communications|October 19, 2022
P300 promotes tumor recurrence by regulating radiation-induced conversion of glioma stem cells to vascular-like cellsSree Deepthi Muthukrishnan, Riki Kawaguchi, Pooja Nair, et al.
AJNR. American Journal of Neuroradiology|December 8, 2025
Focused Ultrasound in Brain Tumors: Mechanisms, Imaging Guidance, and Emerging Clinical ApplicationsAli Nabavizadeh, Kazim Narsinh, Timothy J Kaufmann, et al.
JAMA Oncology|December 26, 2024
Molecular Testing for the World Health Organization Classification of Central Nervous System Tumors: A ReviewCraig Horbinski, David A Solomon, Rimas V Lukas, et al.
Cell Metabolism|January 8, 2019
Obesity-Induced Cellular Senescence Drives Anxiety and Impairs NeurogenesisMikolaj Ogrodnik, Yi Zhu, Larissa G P Langhi, et al.
Contemporary Clinical Trials Communications|May 29, 2026
Protocol for Neuro-Oncology Anywhere: Deploying Mayo Clinic's remote cognitive assessment battery and wearable device monitoring platform while assessing the impact of metformin on cognition and quality of life in patients with history of cranial radiationUgur Sener, Bryan Neth, Taylor Galloway, et al.
Medrxiv : the Preprint Server for Health Sciences|April 29, 2025
Cerebrospinal fluid D-2-hydroxyglutarate for IDH-mutant glioma: utility for detection versus monitoringCecile Riviere-Cazaux, Yuta Suzuki, Zain Kizilbash, et al.
Neuro-Oncology Advances|March 19, 2026
Cerebrospinal fluid D-2-hydroxyglutarate for IDH-mutant glioma monitoringCecile Riviere-Cazaux, Yuta Suzuki, Zain Kizilbash, et al.
Nature Communications|January 12, 2024
Carcinoembryonic antigen-expressing oncolytic measles virus derivative in recurrent glioblastoma: a phase 1 trialEvanthia Galanis, Katharine E Dooley, S Keith Anderson, et al.
Communications Biology|June 20, 2023
Blood-brain barrier disruption defines the extracellular metabolome of live human high-grade gliomasCecile Riviere-Cazaux, Lucas P Carlstrom, Karishma Rajani, et al.
Medrxiv : the Preprint Server for Health Sciences|May 27, 2024
The dynamic impact of location and resection on the glioma CSF proteomeCecile Riviere-Cazaux, Christopher J Graser, Arthur E Warrington, et al.
Pageof 12

Showing results (91-100 of 111) with videos related to

Sort By:
Pageof 12
Nature Communications|October 19, 2022
P300 promotes tumor recurrence by regulating radiation-induced conversion of glioma stem cells to vascular-like cellsSree Deepthi Muthukrishnan, Riki Kawaguchi, Pooja Nair, et al.
AJNR. American Journal of Neuroradiology|December 8, 2025
Focused Ultrasound in Brain Tumors: Mechanisms, Imaging Guidance, and Emerging Clinical ApplicationsAli Nabavizadeh, Kazim Narsinh, Timothy J Kaufmann, et al.
JAMA Oncology|December 26, 2024
Molecular Testing for the World Health Organization Classification of Central Nervous System Tumors: A ReviewCraig Horbinski, David A Solomon, Rimas V Lukas, et al.
Cell Metabolism|January 8, 2019
Obesity-Induced Cellular Senescence Drives Anxiety and Impairs NeurogenesisMikolaj Ogrodnik, Yi Zhu, Larissa G P Langhi, et al.
Contemporary Clinical Trials Communications|May 29, 2026
Protocol for Neuro-Oncology Anywhere: Deploying Mayo Clinic's remote cognitive assessment battery and wearable device monitoring platform while assessing the impact of metformin on cognition and quality of life in patients with history of cranial radiationUgur Sener, Bryan Neth, Taylor Galloway, et al.
Medrxiv : the Preprint Server for Health Sciences|April 29, 2025
Cerebrospinal fluid D-2-hydroxyglutarate for IDH-mutant glioma: utility for detection versus monitoringCecile Riviere-Cazaux, Yuta Suzuki, Zain Kizilbash, et al.
Neuro-Oncology Advances|March 19, 2026
Cerebrospinal fluid D-2-hydroxyglutarate for IDH-mutant glioma monitoringCecile Riviere-Cazaux, Yuta Suzuki, Zain Kizilbash, et al.
Nature Communications|January 12, 2024
Carcinoembryonic antigen-expressing oncolytic measles virus derivative in recurrent glioblastoma: a phase 1 trialEvanthia Galanis, Katharine E Dooley, S Keith Anderson, et al.
Communications Biology|June 20, 2023
Blood-brain barrier disruption defines the extracellular metabolome of live human high-grade gliomasCecile Riviere-Cazaux, Lucas P Carlstrom, Karishma Rajani, et al.
Medrxiv : the Preprint Server for Health Sciences|May 27, 2024
The dynamic impact of location and resection on the glioma CSF proteomeCecile Riviere-Cazaux, Christopher J Graser, Arthur E Warrington, et al.
Pageof 12